Immunosuppressive agents for myasthenia gravis

Background The benefits of different immunosuppressants for myasthenia gravis (MG) are unclear. Objectives Assessment of immunosuppressant drug efficacy in MG. Search methods We searched the Cochrane Neuromuscular Disease Group Trials Register, MEDLINE (from January 1966 to July 2007), EMBASE (from...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2007-10, Vol.2010 (1), p.CD005224
Hauptverfasser:	Hart, Ian K, Sathasivam, Sivakumar, Sharshar, Tarek
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones Adrenal Cortex Hormones - therapeutic use Azathioprine Azathioprine - therapeutic use Azathioprine treatment Child health Cyclophosphamide Cyclophosphamide - therapeutic use Cyclosporine Cyclosporine - therapeutic use Drug Therapy, Combination Humans Immunosuppressive Agents Immunosuppressive Agents - therapeutic use Medicine General & Introductory Medical Sciences Myasthenia Gravis Myasthenia Gravis - drug therapy Mycophenolate Mycophenolic Acid Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use Neurology Neuromuscular junction disorders Prednisolone Prednisolone - therapeutic use Randomized Controlled Trials as Topic Rituximab Tacrolimus Tacrolimus - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!